Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

U.S. Vice President Harris tests positive for COVID-19

Published 04/26/2022, 12:38 PM
Updated 04/27/2022, 12:41 AM
© Reuters. U.S. Vice President Kamala Harris departs from Vandenberg Space Force Base in Lompoc, California, U.S. April 18, 2022. REUTERS/Mike Blake

By Nandita Bose

WASHINGTON (Reuters) -U.S. Vice President Kamala Harris tested positive for COVID-19 on Tuesday but is not exhibiting symptoms, a spokesperson said, at a time when there has been an increase in cases among White House staffers.

Harris has not been in close contact with President Joe Biden or first lady Jill Biden due to their travel schedules, her press secretary, Kirsten Allen, said. Harris will isolate and return to the White House when she tests negative, Allen added.

After consultation with her physicians, Harris was prescribed and has taken antiviral drug Paxlovid, Allen said.

Harris came in to the White House on Tuesday but tested positive and left before meeting Biden, a senior administration official said.

Infections have risen in some parts of the United States due to the highly transmissible Omicron BA.2 subvariant, even as cases are falling overall, according to public health officials.

In recent weeks, second gentleman Doug Emhoff, Harris' communications director Jamal Simmons, White House press secretary Jen Psaki and deputy press secretary Karine Jean-Pierre disclosed positive tests.

Other high-ranking officials to test positive this month have included U.S. House Speaker Nancy Pelosi, next in the line of succession to the presidency after Harris, Attorney General Merrick Garland and Commerce Secretary Gina Raimondo.

Democratic Senators Ron Wyden and Chris Murphy on Tuesday announced that they tested positive for COVID. A senior Senate Democratic aide said because of senators' absences, votes might be delayed on some Biden nominees who face strong opposition from Republicans.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Senate is split 50-50 between Democrats and Republicans. Ties can be broken by Harris, who also is currently unable to come to the Senate to cast such votes.

Administration officials have said recently that President Biden's regular contact with advisers and supporters could expose him to COVID-19.

However, the administration is keen to project a sense of normalcy as many Americans are returning to work and socializing with friends and family, they said.

Both Biden and Harris are fully vaccinated against COVID-19 and have received two booster shots. They have in recent weeks mingled with unmasked guests at the White House, including an event attended by 200 guests with former President Barack Obama to talk about Democrats' signature healthcare law.

With midterm elections scheduled for November, 51% of Americans disapprove of Biden's job performance, according to a Reuters/Ipsos poll, as the country struggles with high inflation and Russia's invasion of Ukraine, pushing Biden, Harris and high-ranking administration officials to travel more and spend more time in large groups without a protective mask.

Latest comments

Nice ad for the new Novovax pill............
too much cackling
Oh gee, I hope she doesn't DIE
and now brought to you by the fake news Reuters
Positively Fked up
Nobody cares
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.